Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

NCT07071038 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Adjuvant Treatment
Early Stage Breast Cancer

Interventions

DRUG: Switch
OTHER: Guideline Directed Intervention (GDI)

Sponsor

Dartmouth-Hitchcock Medical Center